ALBANY MOLECULAR RESEARCH INC
DelistedCIK 1065087fmd_0DE37FH0S9QGZ7A7R7WM9QZMPSServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2017, 30 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 196 | 198 | 208 | 227 | 247 | 277 | 402 | 570 |
| Research and development | 15 | 11 | 8 | 1 | 0 | 1 | 5 | 16 |
| Selling, general and administrative | 38 | 42 | 41 | 41 | 42 | 49 | 77 | 122 |
| Operating income | (22) | (72) | (36) | 1 | 20 | 6 | 14 | (19) |
| Interest expense | 0 | 0 | 1 | 0 | 2 | 11 | 19 | 40 |
| Interest and investment income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Other non-operating income (expense) | (1) | (1) | 0 | (0) | 1 | (0) | 2 | (1) |
| Income before taxes | (22) | (73) | (37) | 0 | 20 | (5) | (3) | (60) |
| Income tax expense | (5) | (10) | (4) | 4 | 8 | (2) | (1) | 10 |
| Net income from continuing operations | (17) | (63) | (32) | (4) | 12 | (3) | (2) | (70) |
| Net income | (17) | (63) | (32) | (4) | 12 | (3) | (2) | (70) |
| Net income to common shareholders | – | – | – | (4) | 12 | (3) | (2) | – |